000			01793 a2200457 4500
005			20250513031038.0
264		0	_c19940902
008			199409s 0 0 eng d
022			_a0027-8424
024	7		_a10.1073/pnas.91.16.7553 _2doi
040			_aNLM _beng _cNLM
100	1		_aCarson, W E
245	0	0	_aThe c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cAug 1994
300			_a7553-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAntigens, CD
650	0	4	_aAntigens, Differentiation, T-Lymphocyte
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBase Sequence
650	0	4	_aCD56 Antigen
650	0	4	_aCell Survival
650	0	4	_aCells, Cultured
650	0	4	_aHematopoietic Cell Growth Factors _xpharmacology
650	0	4	_aHumans
650	0	4	_aKiller Cells, Natural _xdrug effects
650	0	4	_aMolecular Sequence Data
650	0	4	_aProto-Oncogene Proteins _xbiosynthesis
650	0	4	_aProto-Oncogene Proteins c-bcl-2
650	0	4	_aProto-Oncogene Proteins c-kit
650	0	4	_aReceptor Protein-Tyrosine Kinases _xmetabolism
650	0	4	_aReceptors, Colony-Stimulating Factor _xmetabolism
650	0	4	_aStem Cell Factor
650	0	4	_aUp-Regulation
700	1		_aHaldar, S
700	1		_aBaiocchi, R A
700	1		_aCroce, C M
700	1		_aCaligiuri, M A
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 91 _gno. 16 _gp. 7553-7
856	4	0	_uhttps://doi.org/10.1073/pnas.91.16.7553 _zAvailable from publisher's website
999			_c7519250 _d7519250